| have at least one solid point to help |
5.439 |
Jump to 99.68 |
|
|
| enforce those mandates and that is zero |
4.32 |
Jump to 102.56 |
|
|
| one fell swoop has managed to get the |
4.319 |
Jump to 137.92 |
|
|
| authorizations in three pretty large |
3.12 |
Jump to 140.4 |
|
|
| two months and that includes the us |
3.921 |
Jump to 158.239 |
|
|
| shipped our first product to |
4.24 |
Jump to 179.68 |
|
|
| europe we've actually shipped our first |
3.28 |
Jump to 182.239 |
|
|
| product to indonesia we shipped 10 |
3.84 |
Jump to 183.92 |
|
|
| million doses we focused on low and |
5.36 |
Jump to 185.519 |
|
|
| middle income countries first and uh we |
4.8 |
Jump to 187.76 |
|
|
| have to balance in this first quarter as |
4.0 |
Jump to 201.2 |
|
|
| uh rocky at first but it's going great |
4.4 |
Jump to 213.68 |
|
|
| billion doses this year so we're at a |
5.84 |
Jump to 258.0 |
|
|
| over 200 million doses per month by the |
4.24 |
Jump to 263.84 |
|
|
| market for primary vaccination two-dose |
3.919 |
Jump to 272.72 |
|
|
| about as three-dose vaccination |
6.241 |
Jump to 276.639 |
|
|
| is unsatisfied they're 30 to 40 in high |
6.319 |
Jump to 278.88 |
|
|
| income countries there are 30 percent of |
5.12 |
Jump to 282.88 |
|
|
| about a third dose and perhaps a fourth |
4.4 |
Jump to 291.6 |
|
|
| dose boosting you know 90 percent of the |
4.239 |
Jump to 293.52 |
|
|
| you do consider the three doses fully |
4.559 |
Jump to 309.36 |
|
|
| one of the things that we've seen other |
4.0 |
Jump to 312.16 |
|
|
| billion doses of vaccine distributed |
3.84 |
Jump to 336.639 |
|
|
| to our advantage one is that it's it's |
4.96 |
Jump to 357.6 |
|
|
| number two it's stable we've got a |
5.199 |
Jump to 362.56 |
|
|
| stability of nine months instead of six |
4.799 |
Jump to 364.96 |
|
|
| roles that now each one of these vaccine |
3.681 |
Jump to 392.479 |
|
|
| vaccine company one after another hit |
5.76 |
Jump to 467.52 |
|
|
| think about one is tolerability |
4.32 |
Jump to 492.96 |
|
|